Novartis sells Sandoz US dermatology, generics portfolio to Aurobindo for $900m

Novartis sells Sandoz US dermatology, generics portfolio to Aurobindo for $900m

Photo: Reuters

Nivedita Balu

06 September, 2018

Aurobindo Pharma LtdNovartis AGSandoz US

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from India

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.